Company Description
Premier Biomedical, Inc., a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases.
It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors.
It is also developing hemp oil products, including anti-pain patch, roll-on topical products, sprays, ointments, tincture drop product, a hemp oil capsule, and pet product; sequential-dialysis technique for cancer, Alzheimer's disease, ALS, blood sepsis, leukemia, and other life-threatening cancers; and Feldetrex drug candidate for the treatment of multiple sclerosis, fibromyalgia, neuropathic pain, and traumatic brain injuries.
Premier Biomedical, Inc. was founded in 2010 and is headquartered in Jackson Center, Pennsylvania.
| Country | United States |
| Founded | 2010 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 4 |
| CEO | David Caplan |
Contact Details
Address: 5017 River Lakes Parkway Whitefish, Montana 59937-7803 United States | |
| Phone | 312-718-9393 |
| Website | premierbiomedical.com |
Stock Details
| Ticker Symbol | BIEI |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001515740 |
| CUSIP Number | 74048K203 |
| ISIN Number | US74048K2033 |
| Employer ID | 27-2635666 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| David Caplan | President, Chairman of the Board of Directors, Secretary and Treasurer |
| Gustavo Carreño | Chief Technology Officer |
| Carl Eller | Marketing and Planning Vice-President |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 15, 2021 | 15-12G | Securities registration termination |
| Jun 29, 2020 | NT 10-Q/A | Filing |
| Jun 29, 2020 | 8-K/A | [Amend] Current report |
| Jun 29, 2020 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB |
| Jun 1, 2020 | 10-K/A | [Amend] Annual report |
| Jun 1, 2020 | 8-K | Current Report |
| Jun 1, 2020 | 8-K | Current Report |
| May 15, 2020 | 10-K | Annual Report |
| May 15, 2020 | 8-K | Current Report |
| May 15, 2020 | NT 10-K | Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 |